South Australian Medicines Evaluation Panel (SAMEP)
Evaluate High Cost Medicines used in South Australian public hospitals for safety, clinical efficacy and cost-effectiveness.
The Statewide Formulary for High Cost Medicines aims to ensure that eligible patients will have equal opportunity to receive a high cost medicine based upon their clinical condition rather than where they live or what hospital they attend.
All public hospitals must comply with the SA Health Statewide Formulary for High Cost Medicines policy (PDF 281KB) to enhance equity of access within the South Australian public health system.
Formulary applications for high cost medicines should be forwarded to your hospital Drug & Therapeutics Committee. The application should be signed by the Chair of the committee and then forwarded to South Australian Medicines Evaluation Panel (SAMEP) for review. Further information on submitting a formulary application, see the Information for clinicians on submitting a formulary application for a High Cost Medicine (PDF 1377KB) is provided on the following form. SAMEP will then undergo a systematic process of evaluating the medicine for safety, clinical efficacy and cost-effectiveness. SAMEP will consult with specialist clinicians and seek additional external expertise if required.
If you are require a high cost medicine for a single use, please refer to the Individual patient use (IPU) of high cost medicines page.Further information
For further information on Statewide Formulary for High Cost Medicines, contact the South Australian Medicines Evaluation Panel.
For a list of completed review, see the Completed high cost medicine reviews page.
The following medicines are currently being reviewed by the South Australian Medicines Evaluation Panel